ShowcasesPricing
  1. US-listed companies
  2. Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.NTLA

Market cap
$2.2B
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data